Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.
Clinical trial NCT01623596 · COMPLETED
Trial details
- NCT number
- NCT01623596
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-08
- Primary completion
- 2015-07-13
- Enrollment
- 881
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.